Lori Anne Kunkel

Chief Medical Officer, Pharmacyclics.

Companies

Enliven Therapeutics, Inc.Board member Apr 10, 2024 to now¹
Nurix (United States)Board member Jul 23, 2020 to now²
Oric Pharmaceuticals, Inc.Board member Jun 10, 2020 to now³
CURIS INCBoard member Nov 14, 2016 to Jan 31, 2022⁴
Forte Biosciences, Inc.Board member Apr 12, 2017 to Oct 4, 2019⁵
Forte Biosciences, Inc.Acting-Chief Medical Officer Feb 26, 2019 to Feb 26, 2019⁶
PharmacyclicsChief Medical Officer Dec 5, 2011 to May 1, 2013⁷

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

As of each latest filing. The line shows shares held over time.

Jul 6, 2026Sold 5,889 shares at $50.84 of Enliven Therapeutics, Inc.⁸
Jul 6, 2026Sold 4,111 shares at $49.98 of Enliven Therapeutics, Inc.⁸
Jun 5, 2026Sold 354 shares at $35.82 of Enliven Therapeutics, Inc.¹¹
Jun 5, 2026Sold 1,867 shares at $35.36 of Enliven Therapeutics, Inc.¹¹
Jun 5, 2026Sold 7,779 shares at $34.28 of Enliven Therapeutics, Inc.¹¹
Dec 17, 2025Exercised options 15,958 shares at $1.12 of Enliven Therapeutics, Inc.¹²
Dec 8, 2025Exercised options 10,000 shares at $7.90 of Oric Pharmaceuticals, Inc.⁹
Dec 4, 2025Exercised options 5,534 shares at $3.75 of Oric Pharmaceuticals, Inc.¹³
Mar 3, 2025Exercised options 20,500 shares at $6.33 of Oric Pharmaceuticals, Inc.¹⁴
Mar 3, 2025Exercised options 27,666 shares at $3.75 of Oric Pharmaceuticals, Inc.¹⁴
Jul 17, 2024Gift 54,027 shares of Nurix (United States)¹⁰
Jun 3, 2024Exercised options 20,500 shares at $3.75 of Oric Pharmaceuticals, Inc.¹⁵

The numbers on this page point here. Each one links to the record it came from.